Haystack Oncology: Joel Kaufman

Joel Kaufman has been appointed as CFO of liquid biopsy startup Haystack Oncology. Most recently, he was VP of finance and corporate development at Sema4. Previously, he was chief business officer at Navidea Biopharmaceuticals and an equity research analyst at Goldman Sachs, where he covered diagnostics, medical technology, and other areas.